Polatuzumab Vedotin lyophilized vials 30 mg
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
43624-042 -
Package NDC
43624-042-01 -
SPL ID
5126a2f8-cab5-e4b5-e063-6394a90ab5be
What the source publishes
- Labeler
- BSP Pharmaceuticals S.p.A.
- Active ingredients
- Polatuzumab Vedotin lyophilized vials 30 mg
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Administrative status
- present-in-source-snapshot
- Marketing status
- DRUG FOR FURTHER PROCESSING
- Product type
- DRUG FOR FURTHER PROCESSING
Names this record is found by
Complete source data
{
"name": "Polatuzumab Vedotin lyophilized vials 30 mg",
"splId": "5126a2f8-cab5-e4b5-e063-6394a90ab5be",
"labels": [],
"routes": [],
"labeler": "BSP Pharmaceuticals S.p.A.",
"finished": false,
"packaging": [
{
"description": "3 TRAY in 1 BOX (43624-042-01) / 216 VIAL in 1 TRAY / 6 mL in 1 VIAL",
"package_ndc": "43624-042-01",
"identifierStatus": "well-formed",
"marketing_start_date": "16-OCT-19"
}
],
"productId": "43624-042_5126a2f8-cab5-e4b5-e063-6394a90ab5be",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "43624-042",
"deaSchedule": null,
"genericName": "Polatuzumab Vedotin lyophilized vials 30 mg",
"productType": "DRUG FOR FURTHER PROCESSING",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "POLATUZUMAB VEDOTIN",
"strength": "30 mg/1.88mL"
}
],
"applicationNumber": null,
"marketingCategory": "DRUG FOR FURTHER PROCESSING",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190610",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:43624-042_5126a2f8-cab5-e4b5-e063-6394a90ab5be"